ACS Medicinal Chemistry Letters Table of Contents: 2014, vol. 5, No. 11


In This Issue

In This Issue, Volume 5, Issue 11
Janice Elaine Y. Silverman
1175-1175
Full: PDF (1113 K)

Viewpoint

Recent Progress in Antitumoral Synthetic Vaccines
Cristina Nativi and Olivier Renaudet
1176-1178
Full: PDF (153 K)
Treatment of Amyotrophic Lateral Sclerosis: Lessons Learned from Many Failures
P. Hande Özdinler and Richard B. Silverman
1179-1181
Full: PDF (165 K)

Patent Highlights

Neutrophil Elastase Inhibitors as Potential Anti-Inflammatory Therapies
Ahmed F. Abdel-Magid
1182-1183

Full: PDF (262 K)
Inhibitors of Mutant IDH for the Treatment of Cancer
Ahmed F. Abdel-Magid
1184-1185

Full: PDF (238 K)
Liver X Receptor Agonists for the Treatment of Coronary Heart Disease and Other Disorders
Ahmed F. Abdel-Magid
1186-1187

Full: PDF (255 K)
Pyrazolsulfonamide Agonists of Oxytocin Receptor
Gerard Rosse
1188-1189

Full: PDF (244 K)

Featured Letter

1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain
Emmanuel H. Demont, Paul Bamborough, Chun-wa Chung, Peter D. Craggs, David Fallon, Laurie J. Gordon, Paola Grandi, Clare I. Hobbs, Jameed Hussain, Emma J. Jones, Armelle Le Gall, Anne-Marie Michon, Darren J. Mitchell, Rab K. Prinjha, Andy D. Roberts, Robert J. Sheppard, and Robert J. Watson
1190-1195

Full: PDF (3345 K)

Letters

Enantiopure Cyclopropane-Bearing Pyridyldiazabicyclo[3.3.0]octanes as Selective α4β2-nAChR Ligands
Oluseye K. Onajole, J. Brek Eaton, Ronald J. Lukas, Dani Brunner, Lucinda Thiede, Barbara J. Caldarone, and Alan P. Kozikowski
1196-1201

Full: PDF (757 K)
Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein
Abbarna A. Cumaraswamy, Andrew M. Lewis, Mulu Geletu, Aleksandra Todic, Diego B. Diaz, Xin Ran Cheng, Carla E. Brown, Rob C. Laister, David Muench, Kagan Kerman, H. Leighton Grimes, Mark D. Minden, and Patrick T. Gunning
1202-1206

Full: PDF (2600 K)
Structure Activity Relationships of αv Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl Substituents
James Adams, Edward C. Anderson, Emma E. Blackham, Yin Wa Ryan Chiu, Thomas Clarke, Natasha Eccles, Luke A. Gill, Joshua J. Haye, Harvey T. Haywood, Christian R. Hoenig, Marius Kausas, Joelle Le, Hannah L. Russell, Christopher Smedley, William J. Tipping, Tom Tongue, Charlotte C. Wood, Jason Yeung, James E. Rowedder, M. Jonathan Fray, Thomas McInally, and Simon J. F. Macdonald
1207-1212

Full: PDF (441 K)
Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors
Kerry E. Murphy-Benenato, Nelson Olivier, Allison Choy, Philip L. Ross, Matthew D. Miller, Jason Thresher, Ning Gao, and Michael R. Hale
1213-1218

Full: PDF (2030 K)
Inhibitors of HGFA, Matriptase, and Hepsin Serine Proteases: A Nonkinase Strategy to Block Cell Signaling in Cancer
Zhenfu Han, Peter K. W. Harris, Darin E. Jones, Ryan Chugani, Tommy Kim, Manjula Agarwal, Wei Shen, Scott A. Wildman, and James W. Janetka
1219-1224

Full: PDF (2266 K)
Synthesis and Biological Evaluation of Sophoridinol Derivatives as a Novel Family of Potential Anticancer Agents
Chongwen Bi, Caixia Zhang, Yinghong Li, Sheng Tang, Shenggang Wang, Rongguang Shao, Haigen Fu, Feng Su, and Danqing Song
1225-1229

Full: PDF (862 K)
Discovery of Highly Potent Dual CysLT1 and CysLT2 Antagonist
Satoshi Itadani, Shinya Takahashi, Masaki Ima, Tetsuya Sekiguchi, Manabu Fujita, Yoshisuke Nakayama, and Jun Takeuchi
1230-1234

Full: PDF (522 K)
Dihydropyrrolo[2,3-d]pyrimidines: Selective Toll-Like Receptor 9 Antagonists from Scaffold Morphing Efforts
Manabu Watanabe, Mai Kasai, Hideyuki Tomizawa, Masamitsu Aoki, Kazuo Eiho, Yoshiaki Isobe, and Shigehiro Asano
1235-1239

Full: PDF (530 K)
Aptamer-Facilitated Cryoprotection of Viruses
Shahrokh M. Ghobadloo, Ana Gargaun, Rebecca Casselman, Darija Muharemagic, and Maxim V. Berezovski
1240-1244

Full: PDF (2496 K)
Synthesis, in Vitro Covalent Binding Evaluation, and Metabolism of 14C-Labeled Inhibitors of 11β-HSD1
Daqing Sun, Qiuping Ye, Xuelei Yan, Yosup Rew, Peter Fan, Xiao He, Min Jiang, Dustin L. McMinn, Mario Monshouwer, Hua Tu, and Jay P. Powers
1245-1250

Full: PDF (717 K)
Structure–Metabolism Relationships in the Glucuronidation of d-Amino Acid Oxidase Inhibitors
Sarah C. Zimmermann, Rana Rais, Jesse Alt, Caitlin Burzynski, Barbara S. Slusher, and Takashi Tsukamoto
1251-1253

Full: PDF (262 K)
Design of Fluorine-Containing 3,4-Diarylfuran-2(5H)-ones as Selective COX-1 Inhibitors
Md. Jashim Uddin, Anna V. Elleman, Kebreab Ghebreselasie, Cristina K. Daniel, Brenda C. Crews, Kellie D. Nance, Tamanna Huda, and Lawrence J. Marnett
1254-1258

Full: PDF (283 K)
Picomolar Inhibitors of HIV-1 Reverse Transcriptase: Design and Crystallography of Naphthyl Phenyl Ethers
Won-Gil Lee, Kathleen M. Frey, Ricardo Gallardo-Macias, Krasimir A. Spasov, Mariela Bollini, Karen S. Anderson, and William L. Jorgensen
1259-1262

Full: PDF (2517 K)